1. Home
  2. RR vs MYGN Comparison

RR vs MYGN Comparison

Compare RR & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Richtech Robotics Inc. Class B

RR

Richtech Robotics Inc. Class B

HOLD

Current Price

$2.32

Market Cap

583.6M

Sector

N/A

ML Signal

HOLD

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$4.57

Market Cap

481.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RR
MYGN
Founded
2016
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
583.6M
481.6M
IPO Year
2023
1996

Fundamental Metrics

Financial Performance
Metric
RR
MYGN
Price
$2.32
$4.57
Analyst Decision
Strong Buy
Buy
Analyst Count
1
8
Target Price
$6.00
$7.64
AVG Volume (30 Days)
8.8M
1.6M
Earning Date
01-01-0001
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,045,000.00
$771,400,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$78.28
$5.64
P/E Ratio
N/A
N/A
Revenue Growth
18.99
2.33
52 Week Low
$1.69
$3.76
52 Week High
$7.43
$10.30

Technical Indicators

Market Signals
Indicator
RR
MYGN
Relative Strength Index (RSI) 36.81 40.01
Support Level $1.83 $3.93
Resistance Level $2.33 $5.63
Average True Range (ATR) 0.17 0.34
MACD 0.02 0.02
Stochastic Oscillator 6.00 16.43

Price Performance

Historical Comparison
RR
MYGN

About RR Richtech Robotics Inc. Class B

Richtech Robotics Inc is a robotics and artificial intelligence (AI) technology company focused on developing embodied AI systems that aims to improve the efficiency and productivity of businesses. The company trains proprietary artificial intelligence models on in-house data to operate robotic systems in the real world. It designs, engineers, manufactures, and deploys next generation embodied AI systems to serve a wide range of industries, including food service, retail, industrial manufacturing, automotive, healthcare, and hospitality. The company's offerings include Commercial Robotic Products, Industrial Robotic Products and Data Services. The company generated the majority of its revenue through product revenue (i.e. outright hardware sales).

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Share on Social Networks: